Runimotamab is a chimeric humanized antibody of the IgG1-?? isotype, designed to specifically target CD3E and HER2 receptors. This dual targeting strategy enhances the antibody's ability to mediate immune responses against cells expressing HER2, a receptor tyrosine kinase implicated in the progression of several forms of cancer, including breast and gastric cancers. Runimotamab's engagement of CD3E on T cells potentially facilitates a more direct and potent cytotoxic response, making it a valuable tool for research in cancer immunotherapy and the study of bispecific antibody mechanisms.
Runimotamab is a chimeric humanized antibody of the IgG1-?? isotype, designed to specifically target CD3E and HER2 receptors. This dual targeting strategy enhances the antibody's ability to mediate immune responses against cells expressing HER2, a receptor tyrosine kinase implicated in the progression of several forms of cancer, including breast and gastric cancers. Runimotamab's engagement of CD3E on T cells potentially facilitates a more direct and potent cytotoxic response, making it a valuable tool for research in cancer immunotherapy and the study of bispecific antibody mechanisms.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
